Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bronchite acuta

Bibliografia

Quali fonti bibliografiche considerare per la Bronchite acuta?

Le informazioni contenute nella ricerca Pharmamedix dedicata alla bronchite acuta sono state analizzate con riferimento alle seguenti fonti.

  1. Albert R.H., Am. Fam. Physician, 2010, 82 (11), 1345.

  2. Arcavi L., Benowitz N.L., Arch. Intern. Med., 2004, 164 (20), 2206.

  3. Bai L. et al., J. Epidemiol. Community Health, 2018, 72 (5), 426.

  4. Becker L.A. et al., Cochrane Database Syst. Rev., 2015, 9, CD001726.

  5. Chin T., Acute Bronchitis in Chilhood, in Bronchitis in Children – latest Developments, IntechOpen, 2024 https://www.intechopen.com/chapters/87314.

  6. Cornia P.B., Lipsky B.A., JAMA, 2026, 335 (12), 1084.

  7. Dickson R.P. et al., Annu. Rev. Physol., 2016, 78, 481.

  8. Global Initiative for Chronic Obstructive Lung Disease – GOLD, Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2024 Report (accesso: marzo 2026).

  9. Gonzales R. et al., Ann. Intern. Med., 2001, 134 (6), 521.

  10. Grohskopf L.A. et al., MMWR Recomm. Rep., 2024, 73 (5), 1.

  11. Harris A.M. et al., Ann. Intern. Med., 2016, 164 (6), 425.

  12. Hay A.D., JAMA, 2017, 18 (8), 721.

  13. Irwin R.S. et al., Chest., 2018, 153 (1), 196.

  14. Jain S. et al., NEJM, 2015, 373 (5), 415.

  15. Jefferson T. et al., Cochrane Database Syst. Rev., 2023, 1 (1), CD006207.

  16. Kardos P., Clinical Phytoscience, 2015, 1 (1), 2.

  17. Kardos P. et al., Pharmaceuticals, 2025, 18 (5), 754.

  18. Kemmerich B., Arzneimittelforschung., 2007, 57 (9), 607.

  19. Kinkade S., Long N.A., Am. Fam. Physician, 2016, 94 (7), 560.

  20. Llor C., Bjerrum L., Expert. Rev. Anti Infect. Ther., 2016, 14 (7), 633.

  21. Masci Walter, Omeopatia - Tradizione e attualità, 2003, Tecniche Nuove.

  22. Metlay J.P. et al., Am. J. Respir. Crit. Care Med., 2019, 200 (7), e45.

  23. Mulhem E. et al., Am. Fam. Physician, 2025, 111 (3), 214.

  24. Naderi A. et al., Caspian J. Intern. Med., 2024, 15 (4), 651.

  25. Oduwole O. et al., Cochrane Database Syst. Rev., 2018, 4 (4), CD007094.

  26. Petat H. et al., NPJ Prim. Care Respir. Med., 2025, 35 (1), 28.

  27. Ralston S.L. et al., Pediatrics, 2014, 134 (5), e1474.

  28. Scaglione G. et al., Infect. Dis. Ther., 2025, 14 (5), 1075.

  29. Schraufnagel D.E. et al., Chest, 2019, 155 (2), 417.

  30. Schuetz P. et al., Lancet Infect. Dis., 2018, 18 (1), 95.

  31. Smith S.M. et al., Cochrane Database Syst. Rev., 2017, 6 (6), CD000245.

  32. Victoria C.G. et al., Lancet, 2016, 387 (10017), 475.

  33. Wenzel R.P., Fowler A.A., NEJM, 2006, 355 (20), 2125.

  34. WHO - World Health Organisation, 1993, Research guidelines for evaluating the safety and efficacy of herbal medicines.

  35. Zhang P., Zhou X., Int. Health, 2022, 14 (6), 572.

  36. Zhou H. et al., Chin. Med., 2023, 18 (1), 35.

  37. Zotti N. et al., Health Sci. Rep., 2026, 9 (3), e71870.

 

;